Effects of Light Emitting Diode Irradiation on the Conduction Parameters of the Superficial Radial Nerve
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The introduction of light emitting diode (LED) devices as a novel treatment for pain relief in place of low-level laser warrants fundamental research on the effect of LED devices on one of the potential explanatory mechanisms: peripheral neurophysiology in vivo. A randomized controlled study will be conducted by measuring nerve conduction on the superficial radial nerve of healthy subjects (n=64). One baseline measurement and five post-irradiation recordings (2-min interval each) will be performed of the nerve conduction velocity (NCV) and peak latency (PL) and peak amplitude (PA). The experimental group (=32) will receive an irradiation of 2 J/cm2 with an infrared LED device (Dynatronics Solaris Model 705), while the placebo group will be treated by sham irradiation. The purpose of this study is to investigate the effects of LED light on the conduction velocity and amplitude of the superficial radial nerve.
| Condition | Intervention |
|---|---|
|
Peripheral Neuropathy |
Device: Superluminous light diode |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) |
| Official Title: | Effects of Light Emitting Diode Irradiation on the Conduction Parameters of the Superficial Radial Nerve |
- Nerve conduction velocity (meters per second) [ Time Frame: pre-treatment, 0 min, 2 min, 6 min, 8 min and 10 min after treatment ] [ Designated as safety issue: No ]Change in nerve conduction velocity (m/s) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs
- negative peak latency (milliseconds) [ Time Frame: pre-treatment, 0 min, 2 min, 6 min, 8 min and 10 min after treatment ] [ Designated as safety issue: No ]Change in negative peak latency (ms) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs
- amplitude (microvolts) [ Time Frame: pre-treatment, 0 min, 2 min, 6 min, 8 min and 10 min after treatment ] [ Designated as safety issue: No ]Change in amplitude (micro volt) from pre-treatment to 0 minute (immediately after treatment), and at 2 min intervals after treatment until 10 minutes post treatment occurs
| Enrollment: | 32 |
| Study Start Date: | June 2006 |
| Study Completion Date: | September 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Light Therapy
Application of super luminous diodes light irradiation over the superficial radial nerve
|
Device: Superluminous light diode
900W, 880nm, 1.6 J/cm2 for 30sec
Other Name: Dynatronics Solaris Model 705
|
|
Placebo Comparator: Sham Irradiation
Sham Irradiation over the Superficial Radial Nerve for the same time period as the intervention group
|
Device: Superluminous light diode
900W, 880nm, 1.6 J/cm2 for 30sec
Other Name: Dynatronics Solaris Model 705
|
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- no history of neurological disease, polyneuropathy, peripheral neuropathy or cervical radiculopathy
Exclusion Criteria:
- positive findings during the clinical screening examination suggestive of an underlying neurological disease, polyneuropathy, peripheral neuropathy or cervical radiculopathy.
- a history of a neurological disease, polyneuropathy, peripheral neuropathy or cervical radiculopathy.
Contacts and Locations| United States, Virginia | |
| Shenandoah University Divsion of Physical Therapy | |
| Winchester, Virginia, United States, 22601 | |
| Principal Investigator: | Todd A Telemeco, PhD | Shenandoah University |
More Information
Publications:
| Responsible Party: | Todd Telemeco, Associate Professor, Shenandoah University |
| ClinicalTrials.gov Identifier: | NCT01513148 History of Changes |
| Other Study ID Numbers: | 06-750 |
| Study First Received: | January 9, 2012 |
| Last Updated: | January 16, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Peripheral Nervous System Diseases Neuromuscular Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013